Use of Artificial Neural Networks in a QSAR Study of Anti-HIV Activity for a Large Group of HEPT Derivatives

Journal of Chemical Information and Computer Sciences

Volumn 40, Issue 1, 2000, Pages 147-154

  Jalali Heravi, M ^a   Parastar, F ^a  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CHEMISTRY; REGRESSION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; NEURAL NETWORKS (COMPUTER); REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033628605     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci990314+     Document Type: Article

References (29)

1. Jacobo-Molina, A.; Ding, J.; Nanni, R. G.; Clark, A. D.; Lu, X.; Tantillo, C.; Williams, R. L.; Kamer, G.; Ferris, A. L.; Clerck, P.; Hizi, A.; Hughes, S.; Arnold, E. Crystal Structure of Human Immunodeficiency Virus Type I Reverse Transcriptase Complexed with Double-Stranded DNA at 3.0 A Resolution Shows Bent DNA. Proc. Natl. Acad. Sci. 1993, 90, 6320-6324.
2. Schinazi, R. F. Competitive Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase. Perspect. Drug Disc. Des. 1993, 1, 151-180.
3. INFO Pool: Anti HIV Treatment, http://www.med.ed.ac.uk/ridu.
4. De Clercq, E. HIV 1 Specific RT Inhibitors: Highly Selective Inhibitors of Human Immunodeficiency Virus Type 1 That Are Specifically Targeted at the Viral Reverse Transcriptase. Med. Res. Rev. 1993, 13, 229-258.
5. Baba, M.; Tanaka, H.; De Clercq, E.; Pauwels; R.; Balzarini, J.; Schols, D.; Nakashima, H.; Perno, C. F.; Wolker, R. T.; Miyasaka, T. Highly Specific Inhibitation of Human Immunodeficiency Virus Type 1 by a Novel 6-Substituted Acyclouridine Derivative. Biochem. Biophys. Res. Commun. 1989, 165, 1375-1381.
6. Miyasaka, T.; Tanaka, H.; Baba, M.; Hayaakawa, H.; Walker, R. T.; Balzarini, J.; De Clercq, E. A Novel Lead for Specific Anti-HIV-1 Agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. J Med. Chem. 1989, 32, 2507-2509.
7. Root-Bernstein, R. Aids Dissidents Speak Out. http://www.garvnull.com/ Documents/aids.htm.
8. Hansch, C.; Zhang, L. QSAR of HIV Inhibitors. Bioorg. Med. Chem. Lett. 1992, 2, 1165-1169.
9. Kireev, D. B.; Chrétien, J. R.; Grierson, D. S.; Monneret, C. A 3D QSAR Study of a Series of HEPT Analogous: The Influence of Conformational Mobility on HIV-1 Reverse Transcriptase Inhibitation. J. Med. Chem. 1997, 40, 4257-4264.
10. Gussio, R.; Pattabiraman, N.; Zaharevitz, D. W.; Kellogg, G. E.; Topol, I. A.; Rice, W. G.; Schaeffer, C. A.; Erickson, J. W.; Burt, S. K. All-Atom Models for the Non-Nucleoside Binding Site of HIV-1 Reverse Transcriptase Complexed with Inhibitors: A 3D QSAR Approach. J. Med. Chem. 1996, 39, 1645-1650.
11. Hannongbua, S.; Lawtrakul, L.; Limtrakul, J. Structure-Activity Correlation Study of HIV-1 Inhibitors. Electron and Molecular Parameters. J. Comput.-Aided Mol. Des. 1996, 10, 145-152.
12. Hannongbua, S.; Lawtrakul, L.; Sotriffer, C. A.; Rode, B. M. Comparative Molecular Field Analysis of HIV-1 Reverse Transcriptase in Inhibitors in the Class of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. Quant. Struct.-Act. Relat. 1996, 15, 389-394.
13. Bacheler, L. T.; Rayner, M. M.; Erickson-vitanen, J. L.; Jackson, D. A.; Calabrese, C.; Schadt, M.; Chang, C. H. Nonpeptide Cyclic Cyanoguanidines as HIV-1 Protease Inhibitors: Synthesis, Structure-Activity Relationships, and X-ray Crystal Structure Studies. J. Med. Chem. 1998, 41, 1446-1455.
14. Luco, J. M.; Ferretti, F. H. QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives. J Chem. Inf. Comput. Sci. 1997, 37, 392-401.
15. Wikel, J. H.; Dow, E. R.; Heathman, M. Interpretative Neural Networks for QSAR. Net. Sci. http://www.netsci.org/Science/Combichem/ feature02.html.
16. Tetko, I. V.; Tanchuk, V. Y.; Chentsova, N. P.; Antonenko, S. V.; Poda, G. I.; Kukhar, V. P.; Luik, A. I. HIV-1 Reverse Transcriptase Inhibitor Design using Artificial Neural Networks. J. Med. Chem. 1994, 37, 2520-2526.
17. Werbos, V. Beyond Regression: New Tools for Prediction and Analysis in the Behavioral Sciences. Ph.D. Thesis, Harvard University, 1994.
18. Patterson, D. W. Artificial Neural Networks: Theory and Applications; Simson & Schuster: New York, 1996; Part III, Chapter 6.
19. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, Sh.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and Antiviral Activity of 6-Benzyl Analogs of 1-[(2-Hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents. J. Med. Chem. 1992, 35, 4713-4719.
20. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis; John Wiley and Sons: New York, 1986.
21. MOPAC package, Version 6; U. S. Air Force Academy, Colorado Springs, CO 80840.
22. Stouch, T. R.; Jurs, P. C. A Simple Method for the Representation, Quantification, and Comparison of Volumes and Shapes of Chemical Compounds. J. Chem. Inf. Comput. Sci. 1986, 26, 4-12.
23. Rohrbaugh, R. H.; Jurs, P. C. Descriptors of Molecular Shape Applied in Studies of Structure-Activity and Structure-Property. Anal. Chim. Acta. 1987, 199, 99-109.
24. Hansch, C.; Leo, A.; Hoekman, D. In Hydrophobic, Electronic and Steric Constants; Exploring QSAR, Vol. 2; Heller, S. R., Ed.; American Chemical Society: Washington D.C., 1995; pp 217-304.
25. SPSS for Windows, Statistical Package for IBM PC, SPSS Inc. 1993. http://www.spss.com.
26. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Inouye, N.; Baba, M.; Shigeta, Sh.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and Antiviral Activity of Deoxy Analogs of 1-[2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents. J. Med. Chem. 1995, 38, 2860-2865.
27. Tanaka, H.; Baba, M.; Sakamaki, H.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, Sh.; Walker, R. T.; Balzarini, J.; De Clercq, E. A New Class of HIV-1 Specific 6-Substituted Acyclouridine Derivatives: Synthesis and Anti-HIV-1 Activity 5- or 6-Substituted Analogues of 1-[2-Hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 349-357.
28. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, Sh.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Structure-Activity Relationships of 1-[2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine Analogues: Effect of Substitutions at the C-6 Phenyl Ring and at the C-5 Position on Anti-HIV-1 Activity J. Med. Chem. 1992, 35, 337-345.
29. Good, A. C.; Peterson, S. J.; Richards, W. G. QSAR's from Similarity Matrices. Technique Validation and Application in the Comparison of Different Similarity Evaluation Methods. J. Med. Chem. 1993, 36, 2929-2937.